Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa

International Journal of STD and AIDS

Volumn 23, Issue 10, 2012, Pages

  Hoffmann, Christopher J ^b   Dayal, D ^a   Cheyip, M ^a   McIntyre, J A ^a   Gray, G E ^a   Conway, S ^a   Martinson, N A ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Africa; Co infection; HBsAg; Hepatitis B; Hepatitis C; HIV AIDS; Rapid test; Surface antigen

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CD4 LYMPHOCYTE COUNT; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SOUTH AFRICA;

EID: 84868131672     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009340     Document Type: Article

References (26)

1. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007;7:402-9
2. Thio CL, Seaberg EC, Skolasky RL, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS). Lancet 2002;360:1921-6
3. Hoffmann CJ, Seaberg EC, Young S, et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 2009;23:1881-9
4. Puoti M, Cozzi-Lepri A, Paraninfo G, et al. Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg-and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther 2006;11:567-74
5. Matsumoto A, Tanaka E, Rokuhara A, et al. Efficacy of lamivudine for preventing hepatotocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients. Hepatol Res 2005;32:173-84
6. UNAIDS. Report on the Global HIVAIDS Epidemic 2008. Geneva: Joint United Nations Programme on HIV/AIDS, 2008
7. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999;58:111-5
8. Firnhaber C, Reyneke A, Schulze D, et al. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J 2008;98:541-4
9. Ghebremichael M, Paintsil E, Larsen U. Alcohol abuse, sexual risk behaviors, and sexually transmitted infections in women in Moshi urban district, northern Tanzania. Sex Transm Dis 2009;36:102-7
10. Kapiga S, Kelly C, Weiss S, et al. Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis 2009;36:199-206
11. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998;147:478-87
12. Whittle H, Inskip H, Bradley AK, et al. The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis 1990;161:1112-5
13. You J, Sriplung H, Geater A, et al. Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests. World J Gastroenterol 2008;14:3710-8
14. Kotmire S, Gupta I, Ganguly NK, Koicha M. Study of T-lymphocyte subpopulation in HBsAg-positive pregnant women. Acta Virol 1993;37:459-65
15. Hoffmann CJ, Charalambous S, Martin DJ, et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008;47:1479-85
16. Abdool Karim SS, Thejpal R, Coovadia HM. Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol 1991;20:495-503
17. Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009;49(5 Suppl.): S156-S165
18. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B carrier state. J Infect Dis 1991;163:1138-40
19. Hoffmann CJ, Charalambous S, Thio CL, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS 2007;21:1301-8
20. Ellis LA, Brown D, Conradie JD, et al. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum. J Med Virol 1990;32:249-51
21. Pirillo MF, Bassani L, Germinario EA, et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007;79:1797-801
22. Sutcliffe S, Taha TE, Kumwenda NI, Taylor E, Liomba GN. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr 2002;31:90-7
23. Nyirenda M, Beadsworth MB, Stephany P, et al. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect 2008;57:72-7
24. Randrianirina F, Carod JF, Ratsima E, Chretien JB, Richard V, Talarmin A. Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar. J Virol Methods 2008;151:294-7
25. Oshitani H, Kasolo FC, Mpabalwani M, et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hygiene 1996;90:235-6
26. Rouet F, Chaix ML, Inwoley A, et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abijan, Cote d'Ivoire: the ANRS 1236 Study. J Med Virol 2004;74:34-40